Skip to main content
Fig. 1 | Journal of Nanobiotechnology

Fig. 1

From: Microvesicle-camouflaged biomimetic nanoparticles encapsulating a metal-organic framework for targeted rheumatoid arthritis therapy

Fig. 1

Physicochemical characterization of different formulations. A Ultraviolet-visible spectra of free MTX, bare ZIF-8, and MTX@ZIF-8. B X-ray diffraction patterns. C TGA absorption spectra of ZIF-8 and MTX@ZIF-8. D Size distribution, E size, and F zeta potential of ZIF-8 and MTX@ZIF-8. G–K Transmission electron micrographs of different formulations. L Representative Western blots for TSG101, CD81 and CD9. M Size distribution, N mean diameter, and O zeta potential of MVs, MV/MTX@ZIF-8, and FPD/MV/MTX@ZIF-8. FPD: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate (polyethylene glycol)-2000; MTX: methotrexate; MV: microvesicle; ZIF-8: zeolitic imidazolate framework-8

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us